Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin
Sign Up to like & getrecommendations! Published in 2018 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000001269
Abstract: BACKGROUND No studies have examined the use of topical ingenol mebutate for improvement of photoaged skin. OBJECTIVE To evaluate clinical results of ingenol mebutate gel applied to photoaged skin and to quantify improvement at 7,… read more here.
Keywords: ingenol mebutate; improvement; photoaged skin; gel ... See more keywords
Ingenol Mebutate Gel 0.05% in the Treatment of Anogenital Warts: A Prospective Controlled Trial Comparing It With Topical Podophyllin Solution 25%
Sign Up to like & getrecommendations! Published in 2020 at "Sexually Transmitted Diseases"
DOI: 10.1097/olq.0000000000001165
Abstract: The efficacy of ingenol mebutate 0.05% gel in treatment of anogenital warts is similar to podophylline 25% solution, with further benefit of being much more rapid, but it is accompanied with more pain and skin… read more here.
Keywords: ingenol mebutate; podophyllin solution; treatment; gel ... See more keywords
Ingenol mebutate for mycosis fungoides
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18018
Abstract: Ingenol mebutate is a macrocyclic diterpene ester, naturally found in the sap of the Australian plant Euphorbia peplus, which proved efficacious for actinic keratosis. In clinical routine, we observed local improvement of MF upon application… read more here.
Keywords: dermatology; ingenol mebutate; mycosis fungoides; mebutate ... See more keywords
Erosive pustular dermatosis of the scalp following topical ingenol mebutate for actinic keratoses
Sign Up to like & getrecommendations! Published in 2017 at "Dermatologic Therapy"
DOI: 10.1111/dth.12521
Abstract: Ingenol mebutate gel is an effective treatment for actinic keratoses on the head and body, with local reactions of generally low-tointermediate intensity and short duration usually subside within 15 days (Lebwohl et al., 2012). We… read more here.
Keywords: scalp; guarneri; ingenol mebutate; treatment ... See more keywords
Dermoscopy and reflectance confocal microscopy for monitoring the treatment of actinic cheilitis with ingenol mebutate gel: Report of three cases
Sign Up to like & getrecommendations! Published in 2018 at "Dermatologic Therapy"
DOI: 10.1111/dth.12613
Abstract: Actinic cheilitis (AC) can precede the development of squamous cell carcinoma (SCC) of the lip, a location with higher risk of invasiveness and metastasis. Herein, we reported the use of ingenol mebutate (IngMeb) 0.015% gel… read more here.
Keywords: microscopy; actinic cheilitis; ingenol mebutate; reflectance confocal ... See more keywords
Retrospective analysis of squamous cell carcinoma associated with ingenol mebutate reported to the US Food and Drug Administration
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.14114
Abstract: Dear Editor, On 17 April 2020, the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee suspended ingenol mebutate (Picato; Leo Pharma Inc, Denmark) usage citing evidence for increased squamous cell carcinoma (SCC) risk. In a… read more here.
Keywords: ingenol mebutate; treatment; scc; site ... See more keywords
The use of ingenol mebutate to treat actinic keratosis in standard clinical practice: a prospective phase IV multicenter observational cohort study
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Dermatology"
DOI: 10.1111/ijd.14879
Abstract: Actinic keratosis (AK) is a chronic, precancerous skin disease. Various treatments options exist, including ingenol mebutate gel. The aim of this study was to compare its effectiveness and tolerability as well as the impact of… read more here.
Keywords: ingenol mebutate; standard clinical; actinic keratosis; clinical practice ... See more keywords
Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14803
Abstract: Ingenol mebutate (IngMeb) 0.015% gel is an approved field treatment option for non‐hyperkeratotic non‐hypertrophic actinic keratosis (AK) of face and scalp. Efficacy of IngMeb has been assessed only on a clinical ground, in the majority… read more here.
Keywords: ingenol mebutate; treatment; face scalp; keratosis face ... See more keywords
Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis
Sign Up to like & getrecommendations! Published in 2018 at "BioMed Research International"
DOI: 10.1155/2018/4381019
Abstract: Actinic keratosis (AK) is a common skin lesion in adults which usually occurs on chronically photoexposed areas and considered as a precancerous lesion or a superficial squamous-cell carcinoma. Many classifications have been proposed and its… read more here.
Keywords: dermoscopic; ingenol mebutate; treatment; mebutate treatment ... See more keywords
Pharmacoeconomic evaluations in the treatment of actinic keratoses
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Immunopathology and Pharmacology"
DOI: 10.1177/0394632017697719
Abstract: Actinic keratoses (AKs) develop as a consequence of chronic ultraviolet (UV) exposure and exist on a continuum with squamous cell carcinoma (SCC). As one of the most common conditions treated by dermatologists, AK places a… read more here.
Keywords: ingenol mebutate; treatment; actinic keratoses; evaluations treatment ... See more keywords
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cutaneous Medicine and Surgery"
DOI: 10.1177/12034754221143091
Abstract: Background Recently the production and marketing of ingenol mebutate in the European Union (EU) and Canada was halted due to a possible increased risk of squamous cell carcinoma (SCC) in patients with actinic keratosis (AK).… read more here.
Keywords: cell carcinoma; squamous cell; mebutate; actinic keratosis ... See more keywords